Presight Capital

Divibank is a financing platform that provides businesses with access to growth capital through innovative financial services. It develops software that facilitates customer access to products and services from accredited financial institutions. Divibank's platform is designed to offer credit linked to a business's revenue, allowing for flexible repayment without straining cash flow. By utilizing data from digital marketing campaigns, the platform aims to enhance sales performance while helping entrepreneurs attract new users. This approach enables businesses to leverage their revenue potential and optimize their marketing efforts effectively.

Needle operates as an AI-driven platform for search and agent creation.

Faro provides inexpensive apparel through re-commerce, collaborating with fashion companies to reduce textile waste and dumping at the manufacturing and consumption levels.

ChemomAb Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on addressing fibrosis-related conditions that present significant unmet medical needs. ChemomAb's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of the soluble protein CCL24, which plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently undergoing clinical development, with a primary emphasis on orphan diseases such as Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). The company is advancing three Phase 2 clinical trials for CM-101 in various fibrotic indications, with data anticipated to be reported in the near future.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

Standard Bots Company, established in 2011 and headquartered in New York, specializes in developing robotics platforms for both industrial and domestic applications. The company designs and engineers advanced hardware and software solutions, such as the RO1 robot, with a focus on accessibility and power. Their products aim to automate operations, enhance productivity, and integrate seamlessly into existing workflows across diverse industries.

Pantheon Design specializes in creating advanced 3D printing systems aimed at revolutionizing medium-scale manufacturing. The company focuses on developing flexible manufacturing solutions that cater to hardware innovators and integrators. Its printers are designed to deliver end-use quality parts significantly faster and at a lower cost compared to traditional methods. Pantheon Design's technology boasts industry-leading tolerances, superior surface finishes, and mechanical properties, ensuring that clients can produce high-quality products with ease and efficiency. By streamlining the manufacturing process, Pantheon Design addresses the common challenges faced by businesses in the production of parts, ultimately enhancing productivity and reducing costs.

TERN Group is a technology company that specializes in global healthcare recruitment. It operates an AI-driven platform designed to efficiently source, hire, and relocate top-tier medical and engineering talent from regions like India, North Africa, South Africa, and Central Asia to healthcare systems worldwide. The platform streamlines the complex cross-border hiring process, ensuring transparency, ethics, and cost-effectiveness. It offers features such as job matching, candidate document management, pre-screening, interview scheduling, visa assistance, and onboarding, connecting healthcare talents and recruiters globally.

Duetti is a music fintech company that provides financial solutions tailored for independent musicians. It specializes in purchasing catalog rights and monetizing these assets through data-driven marketing and social media strategies. By offering artists quick access to catalog sales, Duetti unlocks new investment opportunities and empowers musicians to pursue their professional and personal aspirations. The company also delivers data-informed pricing for established tracks, enabling artists to sell individual tracks or portions of their work. Through its innovative approach, Duetti aims to enhance the financial prospects of musicians while maximizing the potential of their musical catalog.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Commons is a company that empowers individuals to transform their purchasing habits into meaningful climate action. Founded in 2018 and based in Oakland, California, Commons offers a consumer-facing application that enables users to track, reduce, and offset the carbon emissions associated with their purchases. The app provides practical tools that help users understand their carbon footprint in real-time, discover methods to minimize emissions, and access a curated selection of high-quality carbon offsets. By leveraging their purchasing power, consumers can collectively contribute to a more sustainable economy, making each transaction an opportunity for positive environmental impact.

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on redefining psychiatry through the integration of patient neurobiology into the drug development process. Utilizing an AI-enabled biomarker platform, the company combines diverse information about patients' brain activity and behavior to create personalized and effective treatment options. Alto Neuroscience is developing several clinical assets, including ALTO-100, ALTO-202, ALTO-101, and ALTO-300, primarily targeting depressive disorders and schizophrenia, identified through independent brain-based biomarkers. By moving away from traditional trial-and-error methods, the company aims to align its innovative therapies with the specific needs of patients, ultimately improving the management of mental health conditions.

Hoxton Farms, based in London, UK, specializes in producing real animal fat without the use of animals. The company employs cell biology and advanced mathematical modeling to cultivate purified animal fat in bioreactors, catering primarily to the meat alternatives industry. This innovative approach enables the creation of cruelty-free fat that can be utilized not only in meat alternatives but also in other sectors such as bakery, confectionery, and cosmetics. By focusing on sustainable and ethical production methods, Hoxton Farms aims to transform the way fat is sourced and used in various products.

Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

Cleerly is a healthcare company focused on transforming the management of coronary artery disease through innovative digital care pathways aimed at preventing heart attacks. By combining advanced clinical science with state-of-the-art artificial intelligence, Cleerly develops a platform that delivers actionable clinical insights for all stakeholders involved in heart care. This platform employs a non-invasive approach to analyze and characterize plaque buildup in coronary arteries, allowing healthcare providers to better identify at-risk patients and facilitate early treatment. Cleerly's data-driven solutions not only enhance the evaluation of cardiovascular disease but also aim to improve patient heart health while delivering value to the healthcare system.

Lilo is a leading invest-and-experience platform in Europe that specializes in fractional property ownership. The company focuses on high-end residential properties situated in desirable locations across some of Europe's most popular cities. Lilo provides users with exclusive access to a curated selection of premium properties, allowing them to purchase ownership shares divided into up to eight fractions. This innovative approach enables members to build a diverse global property portfolio while alleviating the financial and mental burdens typically associated with property investment.

Duetti is a music fintech company that provides financial solutions tailored for independent musicians. It specializes in purchasing catalog rights and monetizing these assets through data-driven marketing and social media strategies. By offering artists quick access to catalog sales, Duetti unlocks new investment opportunities and empowers musicians to pursue their professional and personal aspirations. The company also delivers data-informed pricing for established tracks, enabling artists to sell individual tracks or portions of their work. Through its innovative approach, Duetti aims to enhance the financial prospects of musicians while maximizing the potential of their musical catalog.

Bamba is an Android application designed to assist micro-merchants in Africa in managing their businesses using mobile technology. The application provides essential tools that enable merchants to handle customer management, facilitate payments, and access cash advances based on their future cash flow. Additionally, Bamba's software allows users to record stock levels, enhancing their operational efficiency. By offering these comprehensive services, Bamba empowers micro-merchants to streamline their business processes and improve financial management directly from their smartphones.

Bamba Corp. is an online data collection platform based in Nairobi, Kenya, founded in 2012. The company specializes in facilitating data gathering for various sectors, including market research, education, health, government, infrastructure, and retail. Bamba allows organizations to conduct surveys and collect insights from users worldwide through its cloud-based platform, which can be accessed easily via web browsers. This innovative approach addresses the inefficiencies of traditional paper-based data collection methods, which are often costly and time-consuming. Bamba enhances response rates by incentivizing participants with mobile airtime, available in 122 countries. By leveraging data from SMS, web, and social media, Bamba provides businesses with cost-effective and high-quality consumer insights, enabling them to better understand and reach their target markets.

Earth is the creators of soil transformation, an environmentally-friendly alternative to burial and cremation. Over a 30-day process, they gently transform a body into nutrient-rich soil. Families receive a portion of this soil - to scatter or plant - and the remaining soil is sent to conservation land that we acquire, to restore and protect it for future generations. Their experience is carbon neutral, digital-first and underpinned by best-in-class family care. Earth is headquartered in Seattle, Washington and was founded in 2020.

Rario is a Singapore-based non-fungible token (NFT) marketplace established in 2021, specializing in officially licensed cricket NFTs. The platform enables fans to buy, sell, and trade a variety of digital collectibles, including playing cards, video moments, and cricket artifacts. By facilitating the exchange of these items, Rario allows users to engage with other cricket enthusiasts while also providing opportunities to earn real money. Additionally, the platform offers access to exclusive fan clubs, where participants can take part in quests and win rewards, enhancing the overall fan experience within the cricket community.

Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.

SmithRx is a San Francisco-based company that designs and manages customized pharmacy benefit plans for employers, aiming to enhance employee guidance and satisfaction. Founded in 2016, SmithRx operates on a modern technology platform that emphasizes transparency, efficiency, and data analytics. The company provides a cost-competitive pharmacy benefit management (PBM) model, featuring a pass-through pricing structure, a unified technology system, and high-quality service assurances. Its in-house team combines expertise from various healthcare and technology sectors, including experience from notable companies, to deliver exceptional support and clinical programs. SmithRx focuses on empowering its clients with maximum flexibility and control over their pharmacy benefits, ultimately helping to reduce drug spending and improve the management of prescription benefits. The company's name reflects its commitment to precision and craftsmanship in the pharmacy benefits industry.

Valoreo is an e-commerce holding company that specializes in acquiring, operating, and scaling high-potential e-commerce brands across Latin America. The company targets brands that have demonstrated strong customer satisfaction and success as top sellers in their respective niche categories. In addition to acquiring established brands, Valoreo develops its own in-house brands, enhancing its portfolio and enabling significant growth for its clients. By consolidating outstanding startups and leveraging proven market strategies, Valoreo aims to elevate these brands to their next stage of development in the competitive online marketplace.

FORME, founded in 2020 and based in Los Angeles, California, offers an integrated home fitness platform that focuses on sports and fitness instruction. The company provides interactive wellness and strength training sessions, allowing customers to engage in personalized workouts from the comfort of their homes. In addition to fitness training, FORME’s health coaching services include guidance on nutrition, recovery, sleep, and various lifestyle aspects. Revenue is generated through the sale of connected fitness products, membership fees, and personal training services, positioning FORME as a comprehensive solution for individuals seeking to enhance their fitness and overall well-being.

Cloud Paper, Inc. is a manufacturer based in Seattle, Washington, that produces toilet paper made from 100% bamboo. Founded in 2019, the company is committed to sustainability, using no trees in its manufacturing process and avoiding plastic in its packaging. By creating super-soft paper products from bamboo, Cloud Paper aims to eliminate the environmental impact associated with traditional paper manufacturing, particularly the deforestation cycle. The company's toilet paper is sold directly to consumers through its website, emphasizing eco-friendly practices and materials.

Nana Delivery is an e-commerce and delivery platform that specializes in rapid grocery delivery services. By utilizing a network of dark stores strategically located throughout urban areas, the company ensures that products are stored close to consumers for efficient access. This exclusive focus on online grocery shopping allows Nana Delivery to streamline the processes of product selection, packaging, dispatch, and delivery. As a result, the company provides a convenient, affordable, and accessible grocery shopping experience, enabling customers to receive their orders in just minutes.

Denario is a financial software company that focuses on enhancing cash flow for small and medium-sized businesses (SMBs) and startups through an integrated B2B payments platform. The company's software automates various aspects of business payments, including the automatic receipt of invoices, approval workflows, and payment scheduling. By streamlining these processes, Denario simplifies monthly accounting tasks and allows clients to manage and monitor their financial transactions in a secure and accurate manner, all from a single platform.

Enable Medicine is a biotechnology company founded in 2019 by Aaron Mayer and Sunil Bodapati in Menlo Park, California. The company specializes in a bio-computational platform that facilitates the extraction of insights from diverse biological samples. Its Enable Cloud Platform offers a collaborative ecosystem equipped with tools for generating, visualizing, and analyzing various biological image formats. By providing end-to-end services that include custom panel development, data acquisition through advanced imaging technology, and spatial data analysis, Enable Medicine supports researchers, drug developers, and physicians in creating cellular maps that enhance drug discovery processes. The platform aims to reduce costs and accelerate the time required to achieve scientific insights.

Koniku Inc. is a neurotechnology company based in Berkeley, California, that specializes in the development of co-processors made from biological neurons. Founded in 2015, the company has created innovative technology that enables computers to detect odors, effectively allowing them to "smell." This capability is embodied in the Konikore, a smell processor that can analyze human breath and other bodily fluids to identify diseases before they manifest. Koniku's platform integrates odor positioning and surveillance systems which mimic the sensitivity of biological systems, facilitating applications in healthcare, security, industrial monitoring, and food safety. By leveraging machine learning alongside chemical data collection, Koniku aims to transform everyday environments, such as bathrooms, into data centers that predict health outcomes based on volatile organic compounds.

thirdweb is a developer tool designed to accelerate the creation of web3 applications, including apps, games, tokens, NFTs, marketplaces, and DAOs. Founded in 2020 by Furqan Rydhan and Steven Bartlett, the company is based in San Francisco, California. Its platform offers powerful software development kits (SDKs) that enable developers to easily build web3 apps and deploy both custom and pre-built smart contracts. Additionally, thirdweb provides insights to help users understand their project's performance, making it a comprehensive resource for developers looking to integrate web3 features into their projects.

Peek Travel, Inc. is a travel activities marketplace based in San Francisco, California, specializing in tour operator software that facilitates the discovery and booking of tours and activities across the United States. Founded in 2011, Peek offers a platform that connects customers with a curated selection of experiences, allowing users to easily book activities online. The company empowers operators by providing them with tools to manage and grow their businesses effectively. Peek's website and mobile app serve as marketing channels, generating new customer interest by making thousands of activities accessible and bookable anytime, anywhere. Through its technology, Peek aims to create lasting memories for travelers by connecting them with everyday adventures.

Velocity is a prominent financial solution provider in India, specifically catering to digitally native businesses. Founded in 2020 by Abhiroop Medhekar, Atul Khichariya, and Saurav Swaroop, the company seeks to reshape the landscape of banking and financial services for modern enterprises. Velocity offers a diverse array of financial services, including term loans, revenue-based financing, overdrafts, and payment solutions. It distinguishes itself by providing funding options that do not require equity dilution or personal guarantees, allowing clients to repay loans as a fixed percentage of their future revenues. This innovative approach presents an alternative to traditional venture capital and standard loans, enabling businesses to access necessary funds while maintaining greater control over their financial obligations.

Divibank is a financing platform that provides businesses with access to growth capital through innovative financial services. It develops software that facilitates customer access to products and services from accredited financial institutions. Divibank's platform is designed to offer credit linked to a business's revenue, allowing for flexible repayment without straining cash flow. By utilizing data from digital marketing campaigns, the platform aims to enhance sales performance while helping entrepreneurs attract new users. This approach enables businesses to leverage their revenue potential and optimize their marketing efforts effectively.

Bound is a fintech company that makes FX management easy for every business. The company was founded by Seth Phillips and Daniel Kindler in 2020.

Lindus Health is a clinical research organization that specializes in managing end-to-end clinical trials for healthcare and biotechnology companies. The company offers services such as ethics and IRB submissions, trial monitoring, data management, biostatistics, regulatory affairs, and payor relations. Lindus Health employs an in-house team of clinicians and researchers to accelerate the clinical trial process using its proprietary software platform, Curebase OS, which automates workflows and reduces manual inefficiencies. The company also leverages real-world patient data for precise participant recruitment and smarter trial design, aiming to make clinical trials faster and more cost-effective while improving patient treatment outcomes.

Una Brands is a Singapore-based company founded in 2020 that specializes in acquiring and transforming e-commerce brands into prominent market leaders. It focuses on purchasing category-winning brands known for their strong performance, quality products, and positive customer feedback. By leveraging substantial growth capital, Una Brands aims to accelerate the growth of these businesses and enhance their visibility in the market. The company employs advanced data analytics and artificial intelligence to optimize its processes, providing these brands with a competitive advantage. Through its strategic branding services, Una Brands seeks to help e-commerce businesses evolve into globally recognized and enduring household names.

Blackrock Neurotech is a company dedicated to developing advanced neurotechnology platforms designed to record bio-potentials from both the central and peripheral nervous systems for chronic and acute applications. The company's precision electrode technology is pivotal in numerous global innovations related to brain-computer interfaces (BCI) and neural signal processing and stimulation. Blackrock Neurotech aims to assist individuals with disabilities, enabling them to walk, talk, see, hear, and feel by providing the clinical community with innovative tools and expertise to create novel implantable solutions that enhance human lives.

Grounded Foods Co. is a West Hollywood-based company that specializes in producing plant-based cheeses crafted from cauliflower and hemp seeds. Founded in 2019 by behavioral economist Veronica Fil and international award-winning chef Shaun Quade, the company employs a proprietary fermentation process that utilizes imperfect vegetables to create products that closely resemble the flavor and texture of dairy cheese. Their product lineup includes gruyere style cheese, camembert style cheese, marinated hemp seed feta, and hemp seed cream cheese, all designed to offer high nutritional value while promoting environmental sustainability. Grounded Foods sells its offerings through both retail stores and online channels, aiming to provide consumers with viable dairy-free alternatives.

Perfect Day, Inc. is a pioneering company based in Emeryville, California, that specializes in producing animal-free dairy products. Founded in 2014, the company creates milk, cheese, yogurt, milk proteins, and ice cream that are nutritionally identical to traditional dairy but are made through a fermentation process using plant-based sugars. This innovative approach allows Perfect Day to deliver products that retain the taste, texture, and nutrition of conventional dairy while eliminating concerns related to food safety, environmental impact, and animal welfare. The company's commitment to sustainability and compassion results in nutrient-dense alternatives that are vegan, free from antibiotics, cholesterol, and lactose, catering to a growing market for healthier and more ethical food options.

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Upscalio is a financial services provider that invests in and supports digital brands selling on e-commerce platforms such as Amazon, Myntra, Flipkart, and Nykaa. The company specializes in managing essential operations for these brands, including multi-marketplace management, digital marketing, branding, logistics, sourcing, finance, and overall business operations. By leveraging advanced analytics, Upscalio helps e-commerce businesses enhance their performance and achieve their growth objectives.

Penta Fintech Ltd. is a digital banking platform based in Berlin, Germany, that caters to startups and small to medium-sized enterprises (SMEs). Founded in 2016, Penta offers a streamlined approach to banking by automating bank accounts and invoices, which helps businesses save time and money. The platform enables users to open online banking accounts quickly and manage their cash flows efficiently through cashless banking services. Penta aims to disrupt traditional business banking in Europe and beyond by providing innovative solutions tailored to the needs of self-employed individuals, freelancers, startups, and SMEs.

Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

TMRW Life Sciences is a technology company focused on enhancing the management and care of frozen eggs and embryos within the field of in vitro fertilization (IVF). Founded in 2018 and based in New York, TMRW has developed the world's first automated cryo-management platform that integrates robotic storage and monitoring solutions with a complete digital chain of custody. This innovative approach replaces traditional manual and analog methods, significantly reducing the risk of errors in specimen handling. The TMRW platform combines advanced technology, automation, and intuitive software to modernize the IVF specimen management process, allowing clinics to improve their operations and enhance patient outcomes. The company's leadership team comprises experts in fertility, embryology, cryo-management, automation, software development, and robotics.

Syfe is a licensed investment and savings platform operating across Singapore, Hong Kong, and Australia. It offers fully managed portfolios, cash management solutions, and self-directed investments through its neo-brokerage service, providing users with an all-in-one wealth management solution. Syfe's proprietary algorithm tailors each client's portfolio to their risk profile, maximizing returns while managing risk. The company has raised over US$52 million from prominent investors such as Valar Ventures and Unbound Capital.

Upscalio is a financial services provider that invests in and supports digital brands selling on e-commerce platforms such as Amazon, Myntra, Flipkart, and Nykaa. The company specializes in managing essential operations for these brands, including multi-marketplace management, digital marketing, branding, logistics, sourcing, finance, and overall business operations. By leveraging advanced analytics, Upscalio helps e-commerce businesses enhance their performance and achieve their growth objectives.

Umoja Biopharma is a biotechnology company specializing in innovative immunotherapy aimed at transforming cancer treatment. The company focuses on reprogramming T cells to effectively target cancer within patients' bodies, enhancing the immune response to combat both solid tumors and hematological cancers, which often show poor responses to conventional therapies. Umoja Biopharma's proprietary CAR T-cell gene therapy platform is designed to deliver scalable therapeutic regimens, allowing for tailored treatment options that can be administered to any patient, regardless of tumor type or stage. This approach aims to improve patient outcomes and quality of life by providing a safe and controllable method to attack cancer directly.

Opontia is an e-commerce acquiring company focused on purchasing and growing small businesses across the Middle East and Africa. It specializes in acquiring companies that possess strong home-grown brands and long-term competitive advantages. Opontia aims to simplify the selling process for business owners, ensuring they can receive payment within six weeks of accepting an offer. In addition to facilitating sales, Opontia offers expertise in brand building, product design and launch, logistics, and financing for small and medium enterprises. This comprehensive approach allows Opontia to effectively scale the businesses it acquires while providing a fair and efficient selling experience for owners.

Opontia is an e-commerce acquiring company focused on purchasing and growing small businesses across the Middle East and Africa. It specializes in acquiring companies that possess strong home-grown brands and long-term competitive advantages. Opontia aims to simplify the selling process for business owners, ensuring they can receive payment within six weeks of accepting an offer. In addition to facilitating sales, Opontia offers expertise in brand building, product design and launch, logistics, and financing for small and medium enterprises. This comprehensive approach allows Opontia to effectively scale the businesses it acquires while providing a fair and efficient selling experience for owners.

Blackrock Neurotech is a company dedicated to developing advanced neurotechnology platforms designed to record bio-potentials from both the central and peripheral nervous systems for chronic and acute applications. The company's precision electrode technology is pivotal in numerous global innovations related to brain-computer interfaces (BCI) and neural signal processing and stimulation. Blackrock Neurotech aims to assist individuals with disabilities, enabling them to walk, talk, see, hear, and feel by providing the clinical community with innovative tools and expertise to create novel implantable solutions that enhance human lives.

Una Brands is a Singapore-based company founded in 2020 that specializes in acquiring and transforming e-commerce brands into prominent market leaders. It focuses on purchasing category-winning brands known for their strong performance, quality products, and positive customer feedback. By leveraging substantial growth capital, Una Brands aims to accelerate the growth of these businesses and enhance their visibility in the market. The company employs advanced data analytics and artificial intelligence to optimize its processes, providing these brands with a competitive advantage. Through its strategic branding services, Una Brands seeks to help e-commerce businesses evolve into globally recognized and enduring household names.

Una Brands is a Singapore-based company founded in 2020 that specializes in acquiring and transforming e-commerce brands into prominent market leaders. It focuses on purchasing category-winning brands known for their strong performance, quality products, and positive customer feedback. By leveraging substantial growth capital, Una Brands aims to accelerate the growth of these businesses and enhance their visibility in the market. The company employs advanced data analytics and artificial intelligence to optimize its processes, providing these brands with a competitive advantage. Through its strategic branding services, Una Brands seeks to help e-commerce businesses evolve into globally recognized and enduring household names.

Valoreo is an e-commerce holding company that specializes in acquiring, operating, and scaling high-potential e-commerce brands across Latin America. The company targets brands that have demonstrated strong customer satisfaction and success as top sellers in their respective niche categories. In addition to acquiring established brands, Valoreo develops its own in-house brands, enhancing its portfolio and enabling significant growth for its clients. By consolidating outstanding startups and leveraging proven market strategies, Valoreo aims to elevate these brands to their next stage of development in the competitive online marketplace.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

fortú is the personal finance platform for Latinos and Hispanics

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on redefining psychiatry through the integration of patient neurobiology into the drug development process. Utilizing an AI-enabled biomarker platform, the company combines diverse information about patients' brain activity and behavior to create personalized and effective treatment options. Alto Neuroscience is developing several clinical assets, including ALTO-100, ALTO-202, ALTO-101, and ALTO-300, primarily targeting depressive disorders and schizophrenia, identified through independent brain-based biomarkers. By moving away from traditional trial-and-error methods, the company aims to align its innovative therapies with the specific needs of patients, ultimately improving the management of mental health conditions.

Angiex is a biotechnology company focused on developing vascular-targeted biotherapeutics aimed at treating cancer. Founded by leading scientists, the company specializes in antibody-drug conjugate therapies that address key aspects of endothelial biology, particularly angiogenesis. Angiex's lead product is designed to deliver conjugated payloads directly to the nucleus of tumor cells and to activated endothelium in various cancers and inflamed vessels. This innovative approach facilitates the targeted treatment of solid tumors, including pancreatic, lung, and liver cancers, as well as glioblastoma multiforme. The company operates from LabCentral in Cambridge and leverages intellectual property from Beth Israel Deaconess Medical Center to advance its therapeutic solutions.

Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

Velocity is a prominent financial solution provider in India, specifically catering to digitally native businesses. Founded in 2020 by Abhiroop Medhekar, Atul Khichariya, and Saurav Swaroop, the company seeks to reshape the landscape of banking and financial services for modern enterprises. Velocity offers a diverse array of financial services, including term loans, revenue-based financing, overdrafts, and payment solutions. It distinguishes itself by providing funding options that do not require equity dilution or personal guarantees, allowing clients to repay loans as a fixed percentage of their future revenues. This innovative approach presents an alternative to traditional venture capital and standard loans, enabling businesses to access necessary funds while maintaining greater control over their financial obligations.

ChemomAb Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on addressing fibrosis-related conditions that present significant unmet medical needs. ChemomAb's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of the soluble protein CCL24, which plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently undergoing clinical development, with a primary emphasis on orphan diseases such as Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). The company is advancing three Phase 2 clinical trials for CM-101 in various fibrotic indications, with data anticipated to be reported in the near future.

ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative therapies for mental health disorders, including depression, anxiety, and substance use disorders. ATAI utilizes psychedelic compounds and other therapeutic methods to address these conditions, collaborating with various partners and research institutions to enhance its drug development pipeline. Its clinical-stage product portfolio features therapies such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and others derived from compounds like MDMA and ibogaine. By working with experts in the field, ATAI aims to ensure the efficacy and safety of its treatments. The company has garnered recognition for its contributions to mental health research and has secured partnerships and funding to further its initiatives in transforming mental health care.

Penta Fintech Ltd. is a digital banking platform based in Berlin, Germany, that caters to startups and small to medium-sized enterprises (SMEs). Founded in 2016, Penta offers a streamlined approach to banking by automating bank accounts and invoices, which helps businesses save time and money. The platform enables users to open online banking accounts quickly and manage their cash flows efficiently through cashless banking services. Penta aims to disrupt traditional business banking in Europe and beyond by providing innovative solutions tailored to the needs of self-employed individuals, freelancers, startups, and SMEs.

Valoreo is an e-commerce holding company that specializes in acquiring, operating, and scaling high-potential e-commerce brands across Latin America. The company targets brands that have demonstrated strong customer satisfaction and success as top sellers in their respective niche categories. In addition to acquiring established brands, Valoreo develops its own in-house brands, enhancing its portfolio and enabling significant growth for its clients. By consolidating outstanding startups and leveraging proven market strategies, Valoreo aims to elevate these brands to their next stage of development in the competitive online marketplace.

Hoxton Farms, based in London, UK, specializes in producing real animal fat without the use of animals. The company employs cell biology and advanced mathematical modeling to cultivate purified animal fat in bioreactors, catering primarily to the meat alternatives industry. This innovative approach enables the creation of cruelty-free fat that can be utilized not only in meat alternatives but also in other sectors such as bakery, confectionery, and cosmetics. By focusing on sustainable and ethical production methods, Hoxton Farms aims to transform the way fat is sourced and used in various products.

NewAmsterdam Pharma, established in 2019 and headquartered in Naarden, the Netherlands, is a late-stage biopharmaceutical company dedicated to improving patient care in cardio-metabolic disease populations. The company's primary focus is the development of transformative therapies, with its lead product, obicetrapib, being a next-generation, oral, low-dose CETP inhibitor designed to lower LDL-C levels more effectively than current treatments, particularly for patients with statin intolerance or Arteriosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally-tolerated statin therapy.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. Founded in 1999, the company specializes in developing precision cancer therapeutics, particularly next-generation immunotherapies. Sensei's proprietary drug discovery platform, ImmunoPhage, focuses on understanding the tumor microenvironment to create novel biologics that target tumor-specific antigens and activate both the innate and adaptive immune systems. The company is working on a range of investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which aim to address unmet needs in cancer treatment by selectively disabling immunosuppressive signals or activating immunostimulatory signals within the tumor microenvironment. Through its innovative approach and collaboration with experts in biology, immunology, and oncology, Sensei Biotherapeutics seeks to transform cancer treatment and improve outcomes for patients.

Peptilogics, Inc. is a clinical-stage biotechnology company based in West Mifflin, Pennsylvania, founded in 2013. The company specializes in designing and developing novel peptide therapeutics aimed at addressing the urgent challenge of multidrug-resistant bacterial infections. Peptilogics utilizes a unique computational platform that enhances drug discovery by exploring new chemical design spaces while ensuring the biological viability and manufacturability of potential therapeutics. Their lead candidate, PLG0206, is a broad-spectrum anti-infective peptide that targets prosthetic joint infections and has received both FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation. Through its innovative eCAP (engineered cationic antibiotic peptide) platform, Peptilogics aims to provide effective treatment options against resistant bacteria and biofilms, ultimately improving patient outcomes and affordability in healthcare.

Rational Vaccines is a preclinical stage company focused on developing innovative vaccines to address herpes simplex virus-related diseases. The company is dedicated to creating live-attenuated viral immunotherapeutics and prophylactic vaccine candidates aimed at reducing the spread of the virus and improving the management of symptoms associated with herpes infections. Through its research, Rational Vaccines aspires to revolutionize the treatment, prevention, and diagnosis of herpes and related conditions, ultimately enhancing the quality of life for individuals affected by these diseases.

ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative therapies for mental health disorders, including depression, anxiety, and substance use disorders. ATAI utilizes psychedelic compounds and other therapeutic methods to address these conditions, collaborating with various partners and research institutions to enhance its drug development pipeline. Its clinical-stage product portfolio features therapies such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and others derived from compounds like MDMA and ibogaine. By working with experts in the field, ATAI aims to ensure the efficacy and safety of its treatments. The company has garnered recognition for its contributions to mental health research and has secured partnerships and funding to further its initiatives in transforming mental health care.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Angiex is a biotechnology company focused on developing vascular-targeted biotherapeutics aimed at treating cancer. Founded by leading scientists, the company specializes in antibody-drug conjugate therapies that address key aspects of endothelial biology, particularly angiogenesis. Angiex's lead product is designed to deliver conjugated payloads directly to the nucleus of tumor cells and to activated endothelium in various cancers and inflamed vessels. This innovative approach facilitates the targeted treatment of solid tumors, including pancreatic, lung, and liver cancers, as well as glioblastoma multiforme. The company operates from LabCentral in Cambridge and leverages intellectual property from Beth Israel Deaconess Medical Center to advance its therapeutic solutions.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. Founded in 1999, the company specializes in developing precision cancer therapeutics, particularly next-generation immunotherapies. Sensei's proprietary drug discovery platform, ImmunoPhage, focuses on understanding the tumor microenvironment to create novel biologics that target tumor-specific antigens and activate both the innate and adaptive immune systems. The company is working on a range of investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which aim to address unmet needs in cancer treatment by selectively disabling immunosuppressive signals or activating immunostimulatory signals within the tumor microenvironment. Through its innovative approach and collaboration with experts in biology, immunology, and oncology, Sensei Biotherapeutics seeks to transform cancer treatment and improve outcomes for patients.

Syfe is a licensed investment and savings platform operating across Singapore, Hong Kong, and Australia. It offers fully managed portfolios, cash management solutions, and self-directed investments through its neo-brokerage service, providing users with an all-in-one wealth management solution. Syfe's proprietary algorithm tailors each client's portfolio to their risk profile, maximizing returns while managing risk. The company has raised over US$52 million from prominent investors such as Valar Ventures and Unbound Capital.

Cloud Paper, Inc. is a manufacturer based in Seattle, Washington, that produces toilet paper made from 100% bamboo. Founded in 2019, the company is committed to sustainability, using no trees in its manufacturing process and avoiding plastic in its packaging. By creating super-soft paper products from bamboo, Cloud Paper aims to eliminate the environmental impact associated with traditional paper manufacturing, particularly the deforestation cycle. The company's toilet paper is sold directly to consumers through its website, emphasizing eco-friendly practices and materials.

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.

Razor Group is a global consumer holding company that partners with established e-commerce merchants to acquire and scale their brands. The company invests significant capital and leverages its extensive e-commerce expertise to propel these acquired merchants to the next stage of development. Razor focuses on specific product categories, enhancing long-term brand value, and ensuring first-class customer satisfaction through advanced data analytics and custom-built technology.

Sorare is a Paris-based company that operates a global fantasy football game, allowing users to manage soccer teams using digital non-fungible tokens (NFTs). Founded in December 2018, Sorare provides a platform where fans can collect, trade, and utilize virtual player cards, facilitating an engaging gaming experience that merges traditional fantasy sports with blockchain technology. The company aims to make cryptocurrency enjoyable and accessible through its innovative approach to fantasy football. Users can buy, sell, and trade official digital collectibles using real-life cryptocurrencies, contributing to a vibrant marketplace for sports enthusiasts. Sorare has demonstrated significant growth, achieving $1.8 million in card sales by December 2020.

Penta Fintech Ltd. is a digital banking platform based in Berlin, Germany, that caters to startups and small to medium-sized enterprises (SMEs). Founded in 2016, Penta offers a streamlined approach to banking by automating bank accounts and invoices, which helps businesses save time and money. The platform enables users to open online banking accounts quickly and manage their cash flows efficiently through cashless banking services. Penta aims to disrupt traditional business banking in Europe and beyond by providing innovative solutions tailored to the needs of self-employed individuals, freelancers, startups, and SMEs.

Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

AbCellera is a biotechnology company specializing in antibody discovery and development. It uses an integrated platform combining proprietary hardware, software, tools, and advanced data science to efficiently identify and develop optimal antibodies for clinical use. The company partners with both emerging biotechs and established pharmaceutical companies, leveraging its expertise to accelerate the drug development process and improve patient outcomes.

COMPASS Pathways is a mental health care company based in Cheshire, United Kingdom, with operations in the United States. The company is focused on developing innovative therapies for treatment-resistant depression (TRD) using its proprietary psilocybin formulation, COMP360. Currently undergoing Phase IIb clinical trials, COMP360 aims to provide a new treatment option for patients who have not responded to traditional depression therapies. COMPASS Pathways emphasizes the combination of psilocybin-assisted therapy with psychological support to enhance treatment efficacy. The company is committed to addressing the significant unmet needs in mental health care by advancing evidence-based solutions for those suffering from mental health challenges.

AbCellera is a biotechnology company specializing in antibody discovery and development. It uses an integrated platform combining proprietary hardware, software, tools, and advanced data science to efficiently identify and develop optimal antibodies for clinical use. The company partners with both emerging biotechs and established pharmaceutical companies, leveraging its expertise to accelerate the drug development process and improve patient outcomes.

EnClear Therapies, Inc. is a life sciences company based in Newburyport, Massachusetts, that specializes in developing device-based therapies for neurodegenerative diseases. The company focuses on the delivery and monitoring of cerebrospinal fluid (CSF) and employs a proprietary therapeutic platform designed to remove toxic proteins from the CSF. EnClear's initial products are aimed at enhancing the quality of life for patients suffering from conditions such as Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). Incorporated in 2018, EnClear Therapies is dedicated to advancing treatments that can halt disease progression and extend patient lives.

Unmind Ltd is a mental health platform based in London, United Kingdom, specializing in solutions for workplace well-being. Founded in 2016, Unmind provides clinically-backed tools and training designed to foster healthier and happier organizational cultures. The platform offers a range of learning and development programs that empower employees to assess and improve their mental health. By utilizing aggregated and anonymized insights, Unmind enables organizations to drive positive cultural change and understand the overall well-being of their workforce. Its approach aims to create a proactive environment where individuals can enhance their mental health and contribute to a supportive workplace atmosphere.

Habitas is an experience-driven hospitality company that operates a global membership community centered around clubs and lifestyle hotels. Its locations include clubhouses in New York City and Los Angeles, along with a hotel in Tulum, Mexico. Additional properties are being developed in Malibu, the Bahamas, and Namibia. The company focuses on creating spaces that foster connection and community through events that celebrate shared interests such as music, food, and art. Additionally, Habitas is involved in charitable initiatives, including a program called RISE in Uganda, which underscores its commitment to social impact.

General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.

Starship is a financial technology company based in New York City, established in 2016. It focuses on creating a mobile health savings account (HSA) platform that integrates savings, investing, and health-tracking tools. The application allows users to conveniently manage their health savings through automated investing in index funds, streamlined reimbursements, and a user-friendly mobile interface. Additionally, it offers features such as receipt management, card management, and family account oversight, facilitating tax-free healthcare expenses and promoting financial wellness. Starship aims to simplify the process of saving and investing for healthcare needs, making it accessible and efficient for users.

ChemomAb Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on addressing fibrosis-related conditions that present significant unmet medical needs. ChemomAb's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of the soluble protein CCL24, which plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently undergoing clinical development, with a primary emphasis on orphan diseases such as Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). The company is advancing three Phase 2 clinical trials for CM-101 in various fibrotic indications, with data anticipated to be reported in the near future.

Karma Biotechnologies, Inc. is a biotechnology company based in Los Angeles, California, focused on developing innovative therapies for autoimmune diseases, allergies, and food sensitivities. Established in 2019, the company has introduced Xavines, a precision immunotherapy platform aimed at addressing the critical need for antigen-specific treatments that target only the harmful immune cells responsible for these conditions. Unlike conventional approaches that rely on general immune suppression, Karma's technology is designed to promote antigen-specific immune tolerance in vivo. By leveraging expertise in immunology and lipid nanoparticle engineering, the company aims to create off-the-shelf therapeutics that effectively switch off the rogue immune responses associated with autoimmunity and related disorders, thereby enhancing the treatment landscape for these conditions.

Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at addressing age-related diseases. The company specializes in creating novel molecules that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related conditions. Led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, an experienced biotech entrepreneur, Deciduous Therapeutics is dedicated to promoting a healthier lifespan through its pioneering approach to therapeutics in the aging sector.

EnClear Therapies, Inc. is a life sciences company based in Newburyport, Massachusetts, that specializes in developing device-based therapies for neurodegenerative diseases. The company focuses on the delivery and monitoring of cerebrospinal fluid (CSF) and employs a proprietary therapeutic platform designed to remove toxic proteins from the CSF. EnClear's initial products are aimed at enhancing the quality of life for patients suffering from conditions such as Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). Incorporated in 2018, EnClear Therapies is dedicated to advancing treatments that can halt disease progression and extend patient lives.